Novel polydopamine-modified cobalt catalyst effectively degrades tetracycline via sulfate radical processes, suggesting a new approach for wastewater treatment.
Antibiotics play a crucial role in modern medicine, yet their improper use has resulted in significant contamination of global groundwater. Advanced oxidation processes (AOPs), especially sulfate radical‐based AOPs (SR‐AOPs), offer a promising solution by generating strong oxidizing species to degrade persistent organic pollutants. In this study, we developed a novel monolithic cobalt‐based catalyst, MF@PDA/Co(OH) 2 , fabricated by immobilizing Co(OH) 2 on polydopamine (PDA)‐functionalized melamine foam (MF) through a facile impregnation approach. The PDA modification not only ensures strong Co(OH) 2 adhesion but also minimizes cobalt leaching. Comprehensive characterization confirmed the catalyst's structural integrity, while systematic evaluations demonstrated exceptional stability and reusability in peroxymonosulfate (PMS) activation. Mechanistic investigations revealed a synergistic degradation mechanism involving both radical (•SO 4 − and •OH) and non‐radical ( 1 O 2 and electron transfer) pathways for tetracycline removal. This study presents a scalable strategy for developing efficient, cobalt‐conserving, and durable catalytic materials, advancing practical SR‐AOP applications for antibiotic‐contaminated wastewater remediation.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: